Biotech Hansa Biopharma Reports Third Quarter and Interim Year to Date 2026 Financial Results November 11, 2026
Biotech Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference November 10, 2026
Biotech INOVIO Reports Third Quarter 2026 Financial Results and Recent Business Highlights November 10, 2026
Biotech Immutep Further Expands United States Patent Estate for Efti-Based Combination Therapies November 10, 2026
Biotech Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock November 10, 2026
Biotech Nuvation Bio to Present at the Jefferies Global Healthcare Conference in London November 10, 2026
Biotech Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026. November 10, 2026
Biotech Viking Therapeutics Announces Two Poster Presentations at ObesityWeek® 2026 November 10, 2026
Biotech Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London November 10, 2026